Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone HCl (SM-13496) in Schizophrenia
NCT01614899Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Jul 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Sumitomo Pharma. Started Jul 2012; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01614899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614899.